Polymyositis

Last updated: November 01, 2022

Polymyositis

DMPR

DMPR

Chiari malformation
Syringomyelia
Ischemic stroke
Intracerebral hemorrhage
Epidural hematoma
Subarachnoid hemorrhage
Subdural hematoma
Arteriovenous malformation
Wernicke-Korsakoff syndrome
Broca aphasia
Wernicke aphasia
Concussion and traumatic brain injury
Seizures and epilepsy
Febrile seizure
Tension headache
Cluster headache
Migraine
Alzheimer disease
Vascular dementia
Dementia with Lewy bodies
Frontotemporal dementia
Normal pressure hydrocephalus
Creutzfeldt-Jakob disease
Parkinson disease
Huntington disease
Multiple sclerosis
Central pontine myelinolysis
Transverse myelitis
Acute disseminated encephalomyelitis
JC virus (Progressive multifocal leukoencephalopathy)
Adult brain tumors
Pituitary adenoma
Pediatric brain tumors
Acoustic neuroma (schwannoma)
Brain herniation
Brown-Sequard Syndrome
Cauda equina syndrome
Vitamin B12 deficiency
Friedreich ataxia
Treponema pallidum (Syphilis)
Meningitis
Sturge-Weber syndrome
Neurofibromatosis
Tuberous sclerosis
von Hippel-Lindau disease
Spinal muscular atrophy
Poliovirus
Charcot-Marie-Tooth disease
Guillain-Barre syndrome
Bell palsy
Carpal tunnel syndrome
Erb-Duchenne palsy
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Horner syndrome
Orthostatic hypotension
Congenital neurological disorders: Pathology review
Headaches: Pathology review
Seizures: Pathology review
Cerebral vascular disease: Pathology review
Traumatic brain injury: Pathology review
Spinal cord disorders: Pathology review
Dementia: Pathology review
Central nervous system infections: Pathology review
Movement disorders: Pathology review
Neuromuscular junction disorders: Pathology review
Demyelinating disorders: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors: Pathology review
Neurocutaneous disorders: Pathology review
Hyperphosphatemia
Hypophosphatemia
Hyponatremia
Hypernatremia
Hypermagnesemia
Hypomagnesemia
Hypokalemia
Hyperkalemia
Hypercalcemia
Hypocalcemia
Renal tubular acidosis
Diabetic nephropathy
Lupus nephritis
Membranoproliferative glomerulonephritis
Membranous nephropathy
IgA nephropathy (NORD)
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Retinoblastoma
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hemolytic-uremic syndrome
Antiphospholipid syndrome
Complement deficiency
Vitiligo
Albinism
Bone tumors
Osteochondroma
Chondrosarcoma
Osteomalacia and rickets
Paget disease of bone
Osteoporosis
Osteosclerosis
Muscular dystrophy
Polymyositis
Dermatomyositis
Inclusion body myopathy
Polymyalgia rheumatica
Sjogren syndrome
Rett syndrome

Transcript

Watch video only

In polymyositis, “myos-“ refers to the muscles, “poly-“ means many, and “-itis” refers to inflammation, so polymyositis is an inflammatory disorder which involves many muscle groups around the body.

Polymyositis is an immune- mediated disease, meaning that the immune system attacks the muscles in our own body.

Normally, the cells of the immune system are ready to spot and destroy anything foreign that could cause the body harm.

To help with this, most cells in the body have a set of proteins that combine together to form something called a major histocompatibility complex, or MHC, class I molecule that sits on the surface of their cell membrane.

These surface proteins act kind of like a serving platter, presenting molecules from within the cell for the immune system to continually sample.

Normally though the molecule’s just a sample from the cell, and the immune system recognizes it as harmless, and this is known as a self-antigen, and there’s no response.

But when a cell is actually invaded by a pathogen like a virus, viral antigens are presented on the MHC class I molecule, and that sparks a different immune response.

A type of T-lymphocyte, called a CD8+ T-cell, also known as a cytotoxic T-cell, uses its T-cell receptors to bind to the antigen presented by the MHC class I molecule.

If the cytotoxic T-cell binds strongly, than the antigen is recognized as foreign, and the cytotoxic T-cell secretes a whole lot of perforin and granzymes.

Perforin forms big holes in the infected cell and that allows the granzymes to enter the cell.

Once inside, the granzymes induce apoptosis, or programmed cell death.

As if that weren’t enough, the cytotoxic T-cells have a protein called Fas ligand on their surface, and it binds to a molecule called Fas on the surface of the infected cell.

When these two combine, it triggers a cascade of signaling events inside the target cell that also leads to apoptosis.

Meanwhile, B- lymphocytes that react to the pathogen, can also start producing a whole lot of antibodies.

These antibodies bind the pathogen, and typically prevent it from attacking the host’s cells and, at the same time, “tag” the pathogen for further destruction by other immune cells.

In polymyositis, healthy muscle cells present normal muscle proteins on the MHC class I molecule, and the cytotoxic T-cells inappropriately react and get activated.

That’s because it’s thought that the muscle proteins might look similar to a foreign pathogen.

This is called molecular mimicry, because from the perspective of the cytotoxic T-cell, a host protein is mimicking a foreign protein.

Key Takeaways

Polymyositis is an inflammatory disorder of the muscles, caused mainly by cytotoxic T- cells destroying muscle tissue due to molecular mimicry and resulting in bilateral proximal muscle weakness of large muscle groups. It is characterized by muscle weakness, muscle pain, and difficulty with activities of daily living. Its diagnosis involves elevated serum creatinine kinase and myositis- specific antibodies, and it is treated with corticosteroids and specialized physical exercise.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Polymyositis-dermatomyositis: a clinical review." Postgraduate Medical Journal (1989)
  6. "Cardiac Involvement in Adult Polymyositis or Dermatomyositis: A Systematic Review" Clinical Cardiology (2012)
  7. "Diagnosis of dermatomyositis and polymyositis: a study of 102 cases" Arquivos de Neuro-Psiquiatria (2000)